Safety review record^↗Safety records^↗

GHK-Cu^↗↗

Related names in cited records: Copper tripeptide-1, GHK copper^↗

A copper-binding peptide named in FDA's list of bulk substances under evaluation for non-injectable compounding.^↗↗

Citation markers ↗ open the public records supporting the adjacent statements.

Profile update · July 29, 2026

We added FDA substance-identity aliases to improve search matching. The cited compounding-list status did not change. ²

This version supersedes public version 1.

Evidence summary

What the cited records say

FDA lists GHK-Cu, except injectable routes, in Category 1 for bulk substances under evaluation. That listing does not establish FDA approval, safety, or effectiveness.^↗

This is a source summary, not a medical recommendation. Status may differ by jurisdiction and product.

Cited context

Related records

Organizations named in cited records

U.S. Food and Drug Administration^↗

Dated source history

Updates connected to this profile

No dated update is published for this profile. PeptideScanner does not monitor every source continuously; the current profile summary and cited records remain available below.